A Chicago-based company called R1 RCM that makes software to help healthcare companies track revenue is the buyer. R1 said in a press release that SCI’s customer base represents $225 billion in potential revenue, with its services covering more than 94,000 providers and 1,200 facilities.
“Patient scheduling is a critical component of the revenue cycle process, and yet is too often a major pain point for referring providers and health systems,” R1 CEO Joe Flanagan said in a statement. “With SCI’s capabilities integrated into our leading revenue cycle solution, we believe that R1 offers our customers the broadest and deepest tech-enabled patient intake solution available.”
The deal is scheduled to close in the second quarter of this year. R1 said it plans to fund the acquisition with a combination of cash and debt.
News of SCI’s acquisition comes just a few days after it made a purchase of its own. SCI acquired Tonic Health, a digital platform for making payments, checking into appointments and more. In April 2018, SCI acquired acquired DatStat, a Seattle startup that builds self-service patient health data collection technology